1. Market Research
  2. > Manufacturing
  3. > Industrial Equipment
  4. > Mechanics and Part Market Trends
  5. > CorMatrix Cardiovascular, Inc. - Product Pipeline Analysis, 2016 Update

Summary

CorMatrix Cardiovascular, Inc. (CorMatrix) is a medical device company that develops and delivers biomaterial devices to repair damaged heart tissue. The company’s products include interim bioscaffolds, cardiovascular devices, biomaterials, cardiovascular medical devices, extracellular matrix materials, cardiovascular surgery devices, cross linked materials, ECM products, structural proteins, adhesion glycoproteins, glycosaminoglycans, and marticellular proteins. Its other products comprise CorMatrix ECM products and materials, collagen, elastin, fibronectin, laminin, hyaluronan, heparin sulfate, dermantan sulfate, and others. CorMatrix offers services such as clinical studies, pericardial repair and reconstruction, cardiac tissue repair, vascular repair, ECM technology, clinical information, observation, and case reports, bibliography, and cardiovascular surgery services. The company also provides preclinical studies, research and development, and platform technology commercializing services. CorMatrix is headquartered in Roswell, Georgia, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CorMatrix Cardiovascular, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

CorMatrix Cardiovascular, Inc. - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
CorMatrix Cardiovascular, Inc. Company Snapshot 6
CorMatrix Cardiovascular, Inc. Company Overview 6
Key Information 6
CorMatrix Cardiovascular, Inc. Pipeline Products and Clinical Trials Overview 7
CorMatrix Cardiovascular, Inc. - Major Products and Services 9
CorMatrix Cardiovascular, Inc. Pipeline Products by Development Stage 10
CorMatrix Cardiovascular, Inc. Clinical Trials by Trial Status 12
CorMatrix Cardiovascular, Inc. Pipeline Products Overview 13
CorMatrix ECM - Heart Valve Repair 13
CorMatrix ECM - Heart Valve Repair Product Overview 13
CorMatrix ECM - Heart Valve Replacement 14
CorMatrix ECM - Heart Valve Replacement Product Overview 14
CorMatrix ECM Tricuspid Heart Valve 15
CorMatrix ECM Tricuspid Heart Valve Product Overview 15
CorMatrix ECM Tricuspid Heart Valve Clinical Trial 16
CorMatrix ECM-Postoperative Atrial Fibrillation 17
CorMatrix ECM-Postoperative Atrial Fibrillation Product Overview 17
Injectable CorMatrix ECM 18
Injectable CorMatrix ECM Product Overview 18
Pediatric Prosthetic Trileaflet Valve 19
Pediatric Prosthetic Trileaflet Valve Product Overview 19
CorMatrix Cardiovascular, Inc. - Key Competitors 20
CorMatrix Cardiovascular, Inc. - Key Employees 21
CorMatrix Cardiovascular, Inc. - Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
CorMatrix Cardiovascular, Inc., Recent Developments 23
Feb 09, 2016: CorMatrix Cardiovascular Receives 510(k) Clearance For Its Tyke Implantable Device For Neonate And Infant Cardiac Tissue Repair 23
Feb 03, 2016: CorMatrix Cardiovascular Secures Forty-one (41) U.S. Patents in 2015 Including Additional Prosthetic Heart Valve Patents 24
Aug 18, 2015: Lovell Government Services Awarded a Va Fss Contract for CorMatrix ECM Surgical Implants 24
Jun 16, 2015: CorMatrix Cardiovascular Receives Two Additional U.S. Patents for ECM Biomaterial Compositions 25
Mar 18, 2015: CorMatrix CanGaroo Secures International Approval for South America 26
Mar 04, 2015: CorMatrix Cardiovascular Secures Twelve (12) Additional U.S. Patents for ECM Biomaterial 26
Mar 02, 2015: CorMatrix Receives U.S. FDA Approval for Tricuspid Heart Valve Study 27
Aug 27, 2014: CorMatrix Reports First Human Implant of CorMatrix CanGaroo ECM Envelope 28
Aug 25, 2014: CorMatrix Reports FDA Clearance of CorMatrix CanGaroo ECM Envelope 28
Jul 21, 2014: CorMatrix Reports FDA Clearance of CorMatrix ECM for Vascular Repair 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
CorMatrix Cardiovascular, Inc., Key Facts 6
CorMatrix Cardiovascular, Inc. Pipeline Products and Clinical Trials Overview 7
CorMatrix Cardiovascular, Inc. Pipeline Products by Equipment Type 7
CorMatrix Cardiovascular, Inc. Pipeline Products by Indication 8
CorMatrix Cardiovascular, Inc. Clinical Trials by Trial Status 8
CorMatrix Cardiovascular, Inc., Major Products and Services 9
CorMatrix Cardiovascular, Inc. Number of Pipeline Products by Development Stage 10
CorMatrix Cardiovascular, Inc. Pipeline Products Summary by Development Stage 11
CorMatrix Cardiovascular, Inc. Clinical Trials by Trial Status 12
CorMatrix Cardiovascular, Inc. Clinical Trials Summary 12
CorMatrix ECM - Heart Valve Repair - Product Status 13
CorMatrix ECM - Heart Valve Repair - Product Description 13
CorMatrix ECM - Heart Valve Replacement - Product Status 14
CorMatrix ECM - Heart Valve Replacement - Product Description 14
CorMatrix ECM Tricuspid Heart Valve - Product Status 15
CorMatrix ECM Tricuspid Heart Valve - Product Description 15
CorMatrix ECM Tricuspid Heart Valve - CorMatrix ECM Tricuspid Valve Replacement Safety and Early Feasibility 16
CorMatrix ECM-Postoperative Atrial Fibrillation - Product Status 17
CorMatrix ECM-Postoperative Atrial Fibrillation - Product Description 17
Injectable CorMatrix ECM - Product Status 18
Injectable CorMatrix ECM - Product Description 18
Pediatric Prosthetic Trileaflet Valve - Product Status 19
Pediatric Prosthetic Trileaflet Valve - Product Description 19
CorMatrix Cardiovascular, Inc., Key Employees 21

List of Figures
CorMatrix Cardiovascular, Inc. Pipeline Products by Equipment Type 8
CorMatrix Cardiovascular, Inc. Pipeline Products by Development Stage 10
CorMatrix Cardiovascular, Inc. Clinical Trials by Trial Status 12

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Electricity Generating Public Company Limited - Power Plants and SWOT Analysis, 2016 Update

Electricity Generating Public Company Limited - Power Plants and SWOT Analysis, 2016 Update

  • $ 1000
  • Company report
  • August 2016
  • by Global Data

Electricity Generating Public Company Limited - Power Plants and SWOT Analysis, 2016 Update Summary The report contains a detailed description of the power generation company’s business operations, history, ...

Ratchaburi Electricity Generating Holding Public Company Limited - Power Plants and SWOT Analysis, 2016 Update

Ratchaburi Electricity Generating Holding Public Company Limited - Power Plants and SWOT Analysis, 2016 Update

  • $ 1000
  • Company report
  • August 2016
  • by Global Data

Ratchaburi Electricity Generating Holding Public Company Limited - Power Plants and SWOT Analysis, 2016 Update Summary The report contains a detailed description of the power generation company’s business ...

Kenya Electricity Generating Company Limited (KGEN) - Power - Deals and Alliances Profile

Kenya Electricity Generating Company Limited (KGEN) - Power - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2016
  • by Global Data

Summary Kenya Electricity Generating Company Limited (KenGen) is an electric power generation company. It produces around 80% of electricity consumed in the country. Its principal activity is to generate ...

Ogk 2 Oao (russia)

January 2016 $ 3500

Mvv Energie Ag (germany)

January 2016 $ 3400

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.